Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Casesneurology-neurodisability-and-neuromuscular

Paeds Cases · neurology-neurodisability-and-neuromuscular

Counsel a family on starting levetiracetam for newly diagnosed focal epilepsy — OSCE

OSCE communication and shared decision-making station: explaining the selection, titration and adverse-effect monitoring of levetiracetam to the family of a ten-year-old boy with newly diagnosed focal epilepsy, addressing the behavioural adverse effects, the favourable interaction profile, the monitoring schedule, and the principle of syndrome-driven selection in plain language.

osce communication and shared decision-making2 min readVerification in progress

Target exams

MRCPCH ClinicalRACP DCERCPSC Pediatrics
On this page
Study tools

Target exams

MRCPCH ClinicalRACP DCERCPSC Pediatrics
Prompt
A ten-year-old boy and his parents are in clinic after a diagnosis of focal epilepsy confirmed by EEG and MRI. The paediatrician has recommended levetiracetam as the first-choice medicine. The parents have read online that epilepsy medicines cause rashes, liver damage and behaviour problems, and they want to know why this particular drug was chosen, what to watch for, and whether the uncle's carbamazepine would be simpler. Counsel them.

Candidate brief

You have eight minutes to counsel the parents of a ten-year-old boy with newly diagnosed focal epilepsy, confirmed by EEG and MRI, for whom levetiracetam has been recommended as the first-choice medicine. Use a structured, honest, empathic approach that explains why this drug was selected, addresses the online fears, outlines the adverse effects to watch for, and builds a shared monitoring plan. [1] [5]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this case. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References3ShowHide
  1. [1]Glauser T, Ben-Menachem E, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia, 2013.PMID 23350722
  2. [5]Perucca P, Gilliam FG. Adverse effects of antiepileptic drugs. Lancet Neurol, 2012.PMID 22832500
  3. [9]Jones KEA, Howells R, Mallick AA, et al. NICE guideline review: Epilepsies in children, young people and adults NG217. Arch Dis Child Educ Pract Ed, 2023.PMID 37339862
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousCounsel a family on a new diagnosis of juvenile myoclonic epilepsy — OSCEneurology-neurodisability-and-neuromuscularNextCounsel the parents of a child with a first demyelinating event — OSCEneurology-neurodisability-and-neuromuscular